from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2022c/-

LFCtreatmentdescriptionclass of inhibitor

1.566

Amikacinug/mL Amikacintranslation

1.596

Cap5-10ug/mL Capreomycintranslation

3.042

Rox10-50 ug/mL Roxithromycintranslation

0.942

SM2-5 ug/mL Streptomycintranslation

2.216

Tet5-10 ug/mL Tetracyclinetranslation

-0.151

Rif0.2-5ug/mL Rifampicintranscription

-0.543

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.252

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.036

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.007

CPZ10-50 ug/mL Chlorpromazinerespiration

0.504

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.368

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.765

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.750

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.598

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.115

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.469

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.021

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.047

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.176

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.329

KCN5-20 ug/mL Potassium cyaniderespiration

-0.594

NaN30.2-2 mM Sodium aziderespiration

-0.224

Nigericin50 uM Nigericinrespiration

-0.399

TRC10-150 ug/mL Triclosanrespiration

0.118

TRZ10-25 ug/mL Thioridazinerespiration

2.793

Valinomycin0.5-10 uM Valinomycinrespiration

-1.314

ZnSO42 mM ZnSO4respiration

-0.612

menadione6-10 ug/mL Menadionerespiration

0.153

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.241

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.277

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.285

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.020

NRP_1Non-replicating persistence stage 1dosRassociated

-0.177

Amp0.2mg/mL AmpicillincellWall

-0.553

Cephalexin20-100 ug/mL CephalexincellWall

0.060

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.517

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.261

EMB10-20 ug/mL EthambutolcellWall

0.082

Eta12-40 ug/mL EthionamidecellWall

0.313

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.321

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.154

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.650

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.218

BZA0.12 mg/mL BenzamidearomaticAmides

-0.373

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.060

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.207

H2O24 mM hydrogen peroxideDNAdamaging

-0.432

Levo10 ug/mL LevofloxacinDNAdamaging

-0.090

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.974

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.448

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.330

UVUV-irradiationDNAdamaging

0.131

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.327

Antimycin12.5-50 ug/mL Antimycin A?

-0.624

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.659

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.879

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.493

PA8240.2-2 ug/mL PA-824?

-0.268

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.607

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.296

Verapamil50 uM Verapamil?

-0.943

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.604

methoxatin10-20 ug/mL Methoxatin?